CLOVER HEALTH INVESTMENTS CORP CLOV 深 滬
等待開盤 01-29 09:30:00 美东时间
2.31
-0.050
-2.12%
華盛通- 最 高2.385
- 今 開2.37
- 成交量 655.94万股
- 最 低 2.28
- 昨 收 2.36
- 總市值 11.94亿
- 52周最高 4.80
- 市盈率 靜 --
- 換手率 1.27%
- 52周最低 2.12
- 委 比 -39.02%
- 總股本 5.17亿
- 歷史最高 28.85
- 量 比 0.97
- 振 幅 4.45%
- 歷史最低 0.606
- 每 手 1
- 風險率 0.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Clover Health (CLOV) Slides As Trump Medicare Advantage Shock And UnitedHealth Earnings Hit Insurer Sentiment
Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.
01-28 04:43
期权扫描 | 英特尔期权成交翻倍，看涨期权集体飙升最高涨850%！美光股价创新高，多张看涨期权大涨超200%
英特尔期权成交翻倍，看涨期权集体飙升最高涨850%！美光股价创新高，多张看涨期权大涨超200%；IBRX期权大异动，资金押注长期催化剂>>
01-22 15:00
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Canaccord Genuity Maintains Buy on Clover Health Investments, Maintains $3.7 Price Target
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and maintains $3.7 price target.
01-20 23:40
期权扫描 | 美光市值冲破4000亿美元！期权成交放量逾2倍；超微电脑一Call大单飙涨500%
“存储荒”将延续到2027年！美光期权成交放量逾2倍，市值冲破4000亿美元；超微电脑一Call大单飙涨500%，押注股价升破34.5美元>>
01-20 18:49
Clover Health Stock Is Climbing Wednesday: What's Going On?
Clover Health Investments Corp (NASDAQ: CLOV) stock is rising Wednesday after the company announced that it expects to achieve its first full-year GAAP net income profitability this year.
01-15 00:56
Clover Health rises as Medicare Advantage enrollments climb 53%
Shares of Clover Health Investments (CLOV) traded ~11% higher on Wednesday after the company disclosed that enrollees in its Medicare Advantage (MA) plans rose 53% for the 2026 plan year. As the Annua...
01-14 23:10
Clover Health Projects 2026 Profitability as Membership Surges
Clover Health Investments ( ($CLOV) ) just unveiled an update. On December 16, ...
01-14 21:59
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
<p>Counterpart Health在2025年的主要亮点包括：<br> - **临床质量与财务成果**：超450%的第三方客户医生增长，1500个基点的MCR差异，及全国最高的HEDIS评分。<br> - **临床影响**：早期疾病识别、急性护理利用减少，及在社会经济劣势地区支持患者。<br> - **技术创新**：引入整合语音记录、自然语言查询及 proactive visit summaries，扩展企业级功能。<br> Counterpart通过实现实时洞察，改善慢性病管理，提升护理质量和成本效益，正在重新定义价值导向型医疗的未来。</p>
01-12 13:30
期权扫描 | 美光股价再创新高！多张Call单飙升超1000%；英伟达看涨期权占比逾7成
存储继续狂飙，美光股价再创新高！多张Call单飙升超1000%；英伟达看涨期权占比逾7成，介入FSD领域获资金看好；亚马逊推出网页端AI助手，一Call单大涨近300%>>
01-07 19:21
